ImportantGeneral Updates
Natco Pharma has announced a board meeting to discuss the recent U.S.
Natco Pharma LimitedNATCOPHARM · Filed with the exchange
FDA inspection of its Mekaguda API plant.
The FDA noted one procedural observation, which Natco expects to resolve fully.
The company reaffirms its commitment to cGMP standards and maintaining global product quality.
No financial impact reported.
No comments yet. Be the first.